ZA903228B - Therapeutic agent - Google Patents

Therapeutic agent

Info

Publication number
ZA903228B
ZA903228B ZA903228A ZA903228A ZA903228B ZA 903228 B ZA903228 B ZA 903228B ZA 903228 A ZA903228 A ZA 903228A ZA 903228 A ZA903228 A ZA 903228A ZA 903228 B ZA903228 B ZA 903228B
Authority
ZA
South Africa
Prior art keywords
therapeutic agent
purified chymopapain
papaya proteinase
composition
ppiii
Prior art date
Application number
ZA903228A
Other languages
English (en)
Inventor
Alan John Barrett
John Barrett Alan
David John Buttle
John Buttle David
Daniel Hubert Rich
Hubert Rich Daniel
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of ZA903228B publication Critical patent/ZA903228B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
ZA903228A 1989-04-28 1990-04-27 Therapeutic agent ZA903228B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898909836A GB8909836D0 (en) 1989-04-28 1989-04-28 Therapeutic agent

Publications (1)

Publication Number Publication Date
ZA903228B true ZA903228B (en) 1990-12-28

Family

ID=10655944

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA903228A ZA903228B (en) 1989-04-28 1990-04-27 Therapeutic agent

Country Status (34)

Country Link
US (2) US5380656A (cs)
EP (1) EP0470136B1 (cs)
JP (1) JPH04506003A (cs)
KR (1) KR920701241A (cs)
CN (1) CN1047340A (cs)
AT (1) ATE107660T1 (cs)
AU (1) AU631641B2 (cs)
BG (1) BG60916B1 (cs)
CA (1) CA2056402C (cs)
DD (1) DD296960A5 (cs)
DE (1) DE69010199T2 (cs)
DK (1) DK0470136T3 (cs)
EG (1) EG19583A (cs)
ES (1) ES2055427T3 (cs)
FI (1) FI914995A0 (cs)
GB (1) GB8909836D0 (cs)
GR (1) GR1001011B (cs)
HR (1) HRP930700A2 (cs)
HU (2) HUT58345A (cs)
IE (1) IE64351B1 (cs)
IL (1) IL94227A (cs)
IN (2) IN170683B (cs)
LT (1) LT3827B (cs)
LV (1) LV10200B (cs)
MX (1) MX20503A (cs)
NO (1) NO914206L (cs)
NZ (1) NZ233475A (cs)
PL (1) PL166810B1 (cs)
PT (1) PT93921B (cs)
RO (1) RO112032B1 (cs)
RU (1) RU2074891C1 (cs)
WO (1) WO1990013561A1 (cs)
YU (1) YU87090A (cs)
ZA (1) ZA903228B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909836D0 (en) * 1989-04-28 1989-06-14 Boots Co Plc Therapeutic agent
EP0572547A1 (en) * 1991-02-22 1993-12-08 The Du Pont Merck Pharmaceutical Company SUBSTITUTED $g(a)-AMINOALDEHYDES AND DERIVATIVES
CA2061861A1 (en) * 1991-03-04 1992-09-05 Jonathan Duvick Plant polypeptides with inhibitory activity towards pathogenic microorganisms
CN1060519C (zh) * 1991-05-09 2001-01-10 广西亚热带作物研究所 桄榔植物蛋白酶的提取方法
ATE160617T1 (de) * 1991-10-14 1997-12-15 Cash Eng Res Einlassregelvorrichtung für verdichter
US6753006B1 (en) 1993-02-22 2004-06-22 American Bioscience, Inc. Paclitaxel-containing formulations
WO1994028012A1 (en) * 1993-05-28 1994-12-08 Warner-Lambert Company Hydroxamate inhibitors of endothelin converting enzyme
CA2360740A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
KR20010111277A (ko) 1999-03-15 2001-12-17 추후제출 신규한 프로테아제 억제제 화합물 및 조성물
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
US6703040B2 (en) 2000-01-11 2004-03-09 Intralytix, Inc. Polymer blends as biodegradable matrices for preparing biocomposites
JP4512038B2 (ja) * 2002-12-25 2010-07-28 小森 博達 椎間板変性治療剤
US7169405B2 (en) * 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
EP1778262A1 (en) * 2004-07-06 2007-05-02 TOUDAI TLO, Ltd. Compositions for cancer prevention, treatment, or amelioration comprising papaya extract
CN1320111C (zh) * 2004-08-09 2007-06-06 王美岭 一种制备木瓜凝乳酶的方法
US20060241566A1 (en) * 2005-04-11 2006-10-26 Orthox, Llc Nucleus Extraction from Spine Intervertebral Disc
US8642060B2 (en) * 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for osteal growth
US7771414B2 (en) * 2006-04-24 2010-08-10 Warsaw Orthopedic, Inc. Controlled release devices for therapeutic treatments of spinal discs
US8642059B2 (en) 2006-04-24 2014-02-04 Warsaw Orthopedic, Inc. Controlled release systems and methods for intervertebral discs
US7879027B2 (en) * 2006-04-24 2011-02-01 Warsaw Orthopedic, Inc. Controlled release devices for fusion of osteal structures
US20070265633A1 (en) * 2006-05-11 2007-11-15 Moon Jon K Implement and method to extract nucleus from spine intervertebral disc
US8257938B2 (en) * 2009-02-27 2012-09-04 Medical Diagnostic Laboratories, Llc Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum
JPWO2013038936A1 (ja) * 2011-09-13 2015-03-26 タカラバイオ株式会社 ペルオキシダーゼ反応の停止方法及び反応停止剤
US9375519B2 (en) 2012-06-25 2016-06-28 Surmodics, Inc. Bioerodable poly(etheresteramides) and medical article uses
CN118878631B (zh) * 2024-06-05 2025-04-04 中国海洋大学 一种基于配体垂钓筛选合成牡蛎ace抑制肽的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE270723C (cs) *
US2313875A (en) * 1940-12-17 1943-03-16 Eugene F Jansen Proteolytic enzyme process
US3320131A (en) * 1964-10-23 1967-05-16 Baxter Laboratories Inc Method for the treatment of herniation of intervertebral discs
US3558433A (en) * 1967-11-07 1971-01-26 Baxter Laboratories Inc Process for purification of chymopapain
YU40433B (en) * 1975-02-20 1986-02-28 Lek Tovarna Farmacevtskih Process for obtaining pure, proteolytically active anzymes
DE3212846A1 (de) 1981-04-13 1982-11-04 Sintokogio, Ltd., Nagoya, Aichi Apparat und verfahren zum herstellen eines kerns
DE3278934D1 (en) * 1981-05-13 1988-09-29 Flint Lab Inc Improved chymopapain and method for its production and use
US4719108A (en) * 1981-05-13 1988-01-12 Smith Laboratories, Inc. Chymopapain composition and method for its use
US4439423A (en) * 1981-05-13 1984-03-27 Smith Laboratories, Inc. Chymopapain and method for its use
US4374926A (en) * 1981-05-13 1983-02-22 Smith Laboratories, Inc. Method for the production of improved chymopapain
GB2124233B (en) * 1982-07-19 1985-09-18 Nat Res Dev Synthetic peptides and their preparation
GB2156821A (en) * 1984-04-03 1985-10-16 Simmons James W Process for purifying chymopapain
HU196624B (en) * 1986-12-08 1988-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing chymopapain with high specific activity
GB8909836D0 (en) * 1989-04-28 1989-06-14 Boots Co Plc Therapeutic agent

Also Published As

Publication number Publication date
JPH04506003A (ja) 1992-10-22
CN1047340A (zh) 1990-11-28
EP0470136B1 (en) 1994-06-22
LV10200A (lv) 1994-10-20
GB8909836D0 (en) 1989-06-14
NO914206D0 (no) 1991-10-25
YU87090A (sh) 1992-09-07
RU2074891C1 (ru) 1997-03-10
LTIP1645A (en) 1995-07-25
IN170683B (cs) 1992-05-02
WO1990013561A1 (en) 1990-11-15
KR920701241A (ko) 1992-08-11
BG60916B1 (bg) 1996-06-28
NZ233475A (en) 1991-10-25
IE64351B1 (en) 1995-07-26
ATE107660T1 (de) 1994-07-15
IL94227A0 (en) 1991-01-31
MX20503A (es) 1993-12-01
NO914206L (no) 1991-12-17
BG95362A (bg) 1993-12-24
US5468480A (en) 1995-11-21
CA2056402C (en) 1999-11-16
ES2055427T3 (es) 1994-08-16
DD296960A5 (de) 1991-12-19
EG19583A (en) 1995-09-30
LT3827B (en) 1996-03-25
HU903342D0 (en) 1992-01-28
GR900100315A (en) 1991-09-27
DE69010199D1 (de) 1994-07-28
LV10200B (en) 1995-04-20
IE901538L (en) 1990-10-28
PT93921A (pt) 1990-11-20
HUT58345A (en) 1992-02-28
EP0470136A1 (en) 1992-02-12
US5380656A (en) 1995-01-10
RO112032B1 (ro) 1997-04-30
FI914995A7 (fi) 1991-10-23
HRP930700A2 (en) 1995-06-30
IN173230B (cs) 1994-03-12
PT93921B (pt) 1996-10-31
FI914995A0 (fi) 1991-10-23
CA2056402A1 (en) 1990-10-29
DK0470136T3 (da) 1994-08-01
AU5547290A (en) 1990-11-29
PL166810B1 (pl) 1995-06-30
AU631641B2 (en) 1992-12-03
HU211746A9 (en) 1995-12-28
DE69010199T2 (de) 1994-10-13
GR1001011B (el) 1993-03-31
IL94227A (en) 1994-12-29

Similar Documents

Publication Publication Date Title
GR900100315A (en) Therapeutic agent
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
MY110104A (en) Saccharin derivative proteolytic enzyme inhibitors
ZA894971B (en) Purification and administration of dna repair enzymes
CA2290520A1 (en) Inhibition of p38 kinase activity by aryl ureas
AU1061988A (en) Phosphinothricin-resistance gene active in plants, and its use
EP0211592A3 (en) Pharmaceutical dosage unit
IL84092A0 (en) Glycopeptidic antibiotics
GEP20022672B (en) Pharmaceutical Composition
DE69333639D1 (en) Trypsininhibitoren
ES2002053A6 (es) Procedimiento para la obtencion de peptidos inihiobidores de renina que contienen grupos hidroxi.
ES8707553A1 (es) Procedimiento para la obtencion de un peptido.
AU7037591A (en) Stabilization of t-pa pro
CA2262582A1 (en) Hcg and derivatives as matrix metalloproteases inhibitors
AU5239290A (en) Purification of c.pseudotuberculosis toxin, and cloning and expression of toxin gene
HU912740D0 (en) Solubilisation of tissue plasminogene activator (t-pa)
UA8333A1 (uk) Спосіб лікування септичних захворювань
UA10676A (uk) Штаммбактерій васіllus сіrсulаns бт вкпм в-5622продуцеhт комплексу пектолітичhих фермеhтів і ксілаhази
MX9800891A (es) Mocarhagina, una proteasa del veneno de cobra y usso terapeuticos de la misma.
UA10279A (uk) Спосіб лікування дитячого церебрального паралічу